ArticleJournal for immunotherapy of cancer2023

Treating solid tumors with TCR-based chimeric antigen receptor targeting extra domain B-containing fibronectin.

Zhijie Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.